Winthrop Capital Management, LLC Verona Pharma PLC Transaction History
Winthrop Capital Management, LLC
- $200 Million
- Q2 2024
A detailed history of Winthrop Capital Management, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Winthrop Capital Management, LLC holds 1,235 shares of VRNA stock, worth $35,802. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,235
Previous 1,235
-0.0%
Holding current value
$35,802
Previous $20,000
10.0%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
137Shares Held
66.7MCall Options Held
495KPut Options Held
486K-
Ra Capital Management, L.P. Boston, MA7.63MShares$221 Million1.66% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$162 Million7.62% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$116 Million1.9% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$103 Million7.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.31MShares$96.1 Million2.82% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $1.77B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...